<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03042078</url>
  </required_header>
  <id_info>
    <org_study_id>TJHCDD-ZF-PSVT-20140301</org_study_id>
    <nct_id>NCT03042078</nct_id>
  </id_info>
  <brief_title>Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia</brief_title>
  <acronym>ZFA-PSVT</acronym>
  <official_title>Multi-center, Controlled Trial to Compare the Feasibility, Safety and Efficacy of Zero-fluoroscopic Approach With Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese Academy of Medical Sciences, Fuwai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiangyang Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Guangxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Morristown Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ningbo No. 1 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed to compare the feasibility, safety and efficacy of a zero-fluoroscopic
      approach using Ensite NavX with conventional fluoroscopic approach using Ensite NavX plus
      fluoroscopy for the ablation of paroxysmal supraventricular tachycardia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fluoroscopy is the imagine modality routinely used in catheter ablation of cardiac
      arrhythmias. As we all know,fluoroscopic radiation is harmful both to the patients and the
      operation staffs. Recently,three-dimensional navigation systems have been developed and
      implemented in electrophysiological procedures for guiding catheters inside the heart
      chambers. Among the three-dimensional navigation systems, Ensite NavX is a promising system
      used for zero-fluoroscopic approach for performing catheter ablation of paroxysmal
      supraventricular tachycardia. This study is aimed to compare the feasibility, safety and
      efficacy of a zero-fluoroscopic approach using Ensite NavX with conventional fluoroscopic
      approach using Ensite NavX plus fluoroscopy for the ablation of paroxysmal supraventricular
      tachycardia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural success rate</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immediate success rate</measure>
    <time_frame>one day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence Rate</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total procedure time</measure>
    <time_frame>one day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy time</measure>
    <time_frame>one day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2200</enrollment>
  <condition>Paroxysmal Supraventricular Tachycardia</condition>
  <arm_group>
    <arm_group_label>Zero-fluoroscopic ablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Paroxysmal supraventricular tachycardia will be ablated under the guidance of Ensite NavX and without the use of fluoroscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional fluoroscopic ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paroxysmal supraventricular tachycardia will be ablated under the guidance of Ensite NavX plus fluoroscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zero-fluoroscopic ablation</intervention_name>
    <description>Catheter ablation will be performed under the guidance of Ensite NavX and without the use of fluoroscopy.</description>
    <arm_group_label>Zero-fluoroscopic ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional fluoroscopic ablation</intervention_name>
    <description>Catheter ablation will be performed under the guidance of Ensite NavX plus fluoroscopy.</description>
    <arm_group_label>Conventional fluoroscopic ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Atrioventricular Nodal Reentrant Tachycardia

          -  Atrioventricular Reentrant Tachycardia

        Exclusion Criteria:

          -  Atrial Tachycardia

          -  Organic supraventricular tachycardia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Wang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tongji Hospital Wuhan, Hubei China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yan Wang, PhD</last_name>
    <phone>86-27-83663280</phone>
    <email>newswangyan@tjh.tjmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guangzhi Chen, PhD</last_name>
    <phone>86-27-83662842</phone>
    <email>chengz2003@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Wang, PhD</last_name>
      <phone>+86-13697326307</phone>
      <email>newswangyan@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Guangzhi Chen, PhD</last_name>
      <phone>86-27-83662842</phone>
      <email>chengz2003@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Anselmino M, Sillano D, Casolati D, Ferraris F, Scaglione M, Gaita F. A new electrophysiology era: zero fluoroscopy. J Cardiovasc Med (Hagerstown). 2013 Mar;14(3):221-7. doi: 10.2459/JCM.0b013e3283536555. Review.</citation>
    <PMID>22526222</PMID>
  </reference>
  <reference>
    <citation>Mobinizadeh M, Arabloo J, Hamouzadeh P, Akbari Sari A. A systematic review of the effectiveness of catheter ablation NavX mapping system for treatment of the cardiac arrhythmia. Med J Islam Repub Iran. 2015 Mar 10;29:189. eCollection 2015. Review.</citation>
    <PMID>26034742</PMID>
  </reference>
  <reference>
    <citation>Wang Y, Patel D, Wang DW, Yan JT, Hsia HH, Liu H, Zhao CX, Zuo HJ, Wang DW. Î²1-Adrenoceptor blocker aggravated ventricular arrhythmia. Pacing Clin Electrophysiol. 2013 Nov;36(11):1348-56. doi: 10.1111/pace.12196. Epub 2013 Jun 10.</citation>
    <PMID>23750689</PMID>
  </reference>
  <reference>
    <citation>Lim PB, Robb D, Lambiase PD. Electrophysiology and ablation of arrhythmias. Br J Hosp Med (Lond). 2012 Jun;73(6):312-8. Review.</citation>
    <PMID>22875320</PMID>
  </reference>
  <reference>
    <citation>Brown KR, Rzucidlo E. Acute and chronic radiation injury. J Vasc Surg. 2011 Jan;53(1 Suppl):15S-21S. doi: 10.1016/j.jvs.2010.06.175. Epub 2010 Sep 16. Erratum in: J Vasc Surg. 2012 Feb;55(2):627.</citation>
    <PMID>20843630</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2017</study_first_submitted>
  <study_first_submitted_qc>February 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2017</study_first_posted>
  <last_update_submitted>February 2, 2017</last_update_submitted>
  <last_update_submitted_qc>February 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Yan Wang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Fluoroscopy</keyword>
  <keyword>Ablation</keyword>
  <keyword>Three dimensional</keyword>
  <keyword>Paroxysmal supraventricular tachycardia</keyword>
  <keyword>Radiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Supraventricular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

